+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Steatohepatitis Drugs"

Fatty Liver Treatment Market Report 2025 - Product Thumbnail Image

Fatty Liver Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Fatty Liver Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Fatty Liver Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • November 2024
  • 150 Pages
  • Global
From
Alcoholic steatohepatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Alcoholic steatohepatitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Non-alcoholic Steatohepatitis Treatment Market Size, Share & Trends Analysis Report By Drug (Vitamin E & Pioglitazone, Resmetirom), By Disease Stage, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Thumbnail Image

Non-alcoholic Steatohepatitis Treatment Market Size, Share & Trends Analysis Report By Drug (Vitamin E & Pioglitazone, Resmetirom), By Disease Stage, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • November 2024
  • 110 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Treatment Market Report 2025 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Non-alcoholic Steatohepatitis (NASH) - Global Strategic Business Report - Product Thumbnail Image

Non-alcoholic Steatohepatitis (NASH) - Global Strategic Business Report

  • Report
  • March 2025
  • 179 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Market Report 2025 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Market by Drug Type, Disease Cause, Sales Channel, End User, and Region 2024-2032 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Market by Drug Type, Disease Cause, Sales Channel, End User, and Region 2024-2032

  • Report
  • April 2024
  • 137 Pages
  • Global
From
Nonalcoholic Steatohepatitis (NASH) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Nonalcoholic Steatohepatitis (NASH) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2024 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • July 2024
  • 183 Pages
  • Global
From
Global Non-Alcoholic Steatohepatitis Market (by Drug Type, Application Type, Distribution Type, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027) - Product Thumbnail Image

Global Non-Alcoholic Steatohepatitis Market (by Drug Type, Application Type, Distribution Type, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)

  • Report
  • November 2023
  • 130 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Market: Analysis By Drug Type, By Application Type, By Distribution Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Market: Analysis By Drug Type, By Application Type, By Distribution Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027

  • Report
  • January 2023
  • 130 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Application, and Sales Channel - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Application, and Sales Channel

  • Report
  • April 2022
  • 178 Pages
  • Global
From
Japan Non-Alcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Japan Non-Alcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 267 Pages
  • Japan
From
Nonalcoholic Steatohepatitis (NASH) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Thumbnail Image

Nonalcoholic Steatohepatitis (NASH) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • May 2023
  • 119 Pages
  • Global
From
Nonalcoholic Steatohepatitis (NASH) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Nonalcoholic Steatohepatitis (NASH) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 114 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Epidemiology Analysis and Forecast to 2032

  • Report
  • October 2023
  • 38 Pages
  • Global
From
Loading Indicator

Steatohepatitis drugs are used to treat non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). These drugs are used to reduce inflammation, improve liver function, and reduce the risk of cirrhosis and liver cancer. They can also help to reduce the risk of cardiovascular disease. Commonly used steatohepatitis drugs include vitamin E, pioglitazone, obeticholic acid, and elafibranor. These drugs are part of the larger market of liver and kidney disorder drugs, which also includes drugs used to treat hepatitis, cirrhosis, and other liver and kidney diseases. Some companies in the steatohepatitis drugs market include Gilead Sciences, Intercept Pharmaceuticals, Allergan, Novartis, and Merck. Show Less Read more